2m 2m 2m 2m 2m 2m 2m
Health Discovery (HDVY)
OTC
$0.000001-$0.00010 (-99.00%)
Price as of May 29, 2026- $411.00Market Cap
- -99.00%1-Year Change
- Health Information ServicesIndustry
Health Discovery (HDVY)
$0.000001-$0.00010 (-99.00%)
Annual
Quarterly
12/31/2020 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | 1,000 N/A | |
Cost of Revenue | N/A N/A | |
Gross Profit | 1,000 N/A | |
Sales and Marketing Expense | N/A N/A | |
Research and Development Expense | N/A N/A | |
Depreciation and Amortization Expense | 0 N/A | |
Total Operating Expenses | 1.7M N/A | |
Operating Profit | -1.7M N/A | |
Interest Income | 1,000 N/A | |
Interest Expense | -10,000 N/A | |
Interest Income and Expense and Net | -9,000 N/A | |
Total Nonoperating Income and Expense | 983,000 N/A | |
Income before Taxes | -1.7M N/A | |
Income Taxes | N/A N/A | |
Extraordinary Items | N/A N/A | |
Net Income | -759,000 N/A | |
Net Income from Continuing Operations Applicable to Common | -759,000 N/A | |
Basic EPS and Net Income | -0.002 N/A | |
Diluted EPS and Net Income | -0.002 N/A | |
Basic Weighted Average Shares | 397.6M N/A | |
Diluted Weighted Average Shares | 397.6M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 917,000 N/A | |
Short-Term Investments | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 917,000 N/A | |
Total Current Assets | 932,000 N/A | |
Accumulated Depreciation | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | |
Total Long-Term Assets | N/A N/A | |
Total Assets | 932,000 N/A | |
Income Taxes Payable | N/A N/A | |
Total Short-Term Debt | 212,000 N/A | |
Total Current Liabilities | 557,000 N/A | |
Total Long-Term Debt | N/A N/A | |
Total Long-Term Liabilities | N/A N/A | |
Total Liabilities | 557,000 N/A | |
Retained Earnings | -30.1M N/A | |
Total Stockholders Equity | 375,000 N/A | |
Total Shares Outstanding | 404.0M N/A | |
Cash Flow | ||
Cash from Operating Activities | -1.4M N/A | |
Capital Expenditures | N/A N/A | |
Cash from Investing Activities | N/A N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 0 N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | -174,200.00% N/A | |
Return on Assets | -46.79% N/A | |
Return on Equity | 1,589.41% N/A | |
Revenue Growth | -99.93% N/A | |
Current Ratio | 1.67 N/A | |
Cash Ratio | 1.65 N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow